EnsoData has received FDA 510(k) clearance for technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry devices, the company announced this week. “Expanding EnsoData’s capability to collect and analyze…
EnsoData is partnering with React Health, a sleep and respiratory device manufacturer, to optimize positive airway pressure (PAP) adherence support for patients with sleep apnea, the company announced recently. “Out…
EnsoData has assisted clinicians in diagnosing the one millionth patient supported by its AI/ML sleep scoring solution, EnsoSleep, the company announced today. “Now that we have helped clinicians read one…
EnsoData named Justin Mortara as the new CEO, the company announced recently. According to a release, Mortara, who is taking over the role of CEO from co-founder Chris Fernandez, is…
EnsoData has closed a $20 million Series A extension round, which was led by Inspire Medical Systems, the company announced today. According to a release, the funds will be used…
EnsoData announced today its FDA 510(k) clearance of new capabilities and enhancements to its product, EnsoSleep. According to a release, the updates will help sleep clinicians provide care more efficiently,…
EnsoData announced today that it closed a $9 million Series A financing round. According to a release, the funds will be used to launch new AI products in sleep and…
EnsoData announced this week it has partnered with LabRetriever to help sleep clinicians save time, increase clinic efficiency and potentially increase revenue. According to a release, LabRetriever is a sleep…
EnsoData received clearance from the U.S. Food and Drug Administration on its EnsoSleep software, the company announced recently. According to a release, EnsoSleep’s clinical performance was validated in a clinical study…
EnsoData, a healthcare data company, announced today that it raised $550,000 for working capital and to grow its sales and data science teams. According to a release, HealthX Ventures led the funding round….
